EUVIMEDEUVIMED entdecken
Crossref

Case Series of Irinotecan-Induced-Dysarthria: A Review of Literature and Proposition of a Pre-Medication Regimen

Ahmed Khattab, Seon Jo Park, Sunita Patruni, Nour Daboul, Dulabh K Monga

Mathews Journal of Gastroenterology & Hepatology · 2019

DOI: 10.30654/mjgh.10001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathews Journal of Gastroenterology & Hepatology, 2019. Verfasst von Ahmed Khattab und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irinotecan is a topoisomerase-I inhibitor that is commonly used in combination with other chemotherapy agents for gastrointestinal malignancies.It has been found to induce transient dysarthria during infusion which has prompted premature cessation.We encountered 3 patients on FOLFIRINOX who experienced dysarthria-like symptoms during irinotecan infusion.Through a literature review and prospective observational study done at our tertiary care facility, we devised a pre-medication regimen which included extending the irinotecan infusion to 3 hours, replacement of all electrolytes to the upper limits of normal and the addition of atropine during infusion.These steps were to be taken in addition to the standard pre-medications to prevent known side effects of nausea, diarrhea and cholinergic syndrome.During subsequent irinotecan infusion sessions for our 3 patients, we exposed them to our proposed pre-medication regimen which resulted in toleration of therapy and dysarthria-free or significant attenuation of symptoms.The purpose of this case series is to promote further awareness of this unusual reaction as well as to propose a standard pre-medication regimen with all subsequent irinotecan administrations in the event a patient develops dysarthria on initial therapy.

Zitieren

APA

Khattab, A., Park, S. J., Patruni, S., Daboul, N., & Monga, D. K. (2019). Case Series of Irinotecan-Induced-Dysarthria: A Review of Literature and Proposition of a Pre-Medication Regimen. Mathews Journal of Gastroenterology & Hepatology. https://doi.org/10.30654/mjgh.10001

Vancouver

Khattab A, Park SJ, Patruni S, Daboul N, Monga DK. Case Series of Irinotecan-Induced-Dysarthria: A Review of Literature and Proposition of a Pre-Medication Regimen. Mathews Journal of Gastroenterology & Hepatology. 2019. doi:10.30654/mjgh.10001

BibTeX
@article{Khattab2019,
  author = {Khattab, Ahmed and Park, Seon Jo and Patruni, Sunita and Daboul, Nour and Monga, Dulabh K},
  title = {Case Series of Irinotecan-Induced-Dysarthria: A Review of Literature and Proposition of a Pre-Medication Regimen},
  journal = {Mathews Journal of Gastroenterology & Hepatology},
  year = {2019},
  doi = {10.30654/mjgh.10001}
}
Kostenlos starten →